CryoPort Inc (CYRX)

[Rev3lation]

CYRX Financial Analysis - Enjoy

Gross Margin Increase 9.52% - 2016 to 1017 - This is awesome. They continued the roughtly 10% growth in Gross margin Year over Year.
I know I promised some new cash flow numbers. Sorry on the dealy things have been crazy on my end.

My Financial Analysis of CYRX for 2016 to 2017
------------------

Total Cash reported for EOY was $15,052,189

In 2017 Take the Cost of Goods and divide by 12 getting Monthly cost.
$5,987,834/12 = $498,986

Then take your cash and divide by the monthly cost.
$15,052,189/$498,986= 30.15 Months of cash if cost stay same. This is an increase from last year if you recall we only had 20 Months of cash from my last post on Finance.

This is awesome. If you factor in also the increase in Accounts receivable.

Now to cover the break down of increased costs between 2016 and 2017.
General and administrative $971,641 - 13.09%
Sales and marketing $412,176 7.88%
Engineering and development $607,586 - 50.39%
In total that is $1,991,403

Since our Gross margin increased from
$3,101,423 to $5,966,433 the 9.52% this is $2,865,010 Increase we can used against our costs

This next numbers shows our gross margin increasing faster than COSTS <<< AWESOME JOB
$2,865,010-$1,991,403 = $873,607

This is effectively the first time we saw a drop in Loss from Operations <<< AWESOME JOB
From $8,766,109 to $7,892,502

In summary with 30 months of cash and increasing gross margin. I am still long this stock for a buyout and growth potential.
I think the increase volumes lately are from institutions realizing the same thing.

I have to say Thank you to the management of Cryoport keep up the great work. I feel strongly that 2018 and 2019 will be great years.

------------------------
Conference Call Notes:
Link to Listen to Call

Personally, I am a numbers guy but I do listen to the direction to ensure management is on task with continuing these numbers.

Ramping up of 2 centers will add some costs, but the ramp up will be timed with the ramping up of customers.
It was good to see they are forecasting these patients estimates before investing full in these centers.
This is critical in maintaining growth in revenue while not overrunning costs.

$2-20 Mil revenue potential from each commercialized.
I really like this number, and can see this being great.

I wonder if McKesson would potential be a company that may want to buy us out and integrate us. We don't want to do this yet until we generate more value for CryoPort over the next 2 years.

By far this is the best call with the most information for the public on CryoPort performance and details.

I really like the CryoStork and C3 services, which they discussed on the call.

I feel like during the Q&A - Jerry really laid them out on profitability. It was awesome...LOL -Hopefully the person that asked the question went back and did the math to understand the growth of costs relative to the growth in revenue. This is what is used to build us value.

--------------------

Disclaimer: I have owned this stock for almost 10 years now. I am long Cryoport. My analysis is my own. I am just sharing for others.
I am not a certified financial advisor, and you should always make your own investment decisions.

---------------------
We are making lives and saving lives here. I am excited.